<?xml version="1.0"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <meta name="generator" content="HTML Tidy, see www.w3.org" />
    <base
    href="http://www.cirp.org/library/treatment/BXO/dahlman-ghozlan1/" />

    <title>Penile lichen sclerosus et atrophicus treated with
    clobetasol dipropionate 0.05% cream</title>
    <meta name="robots" content="index, follow" />
    <meta name="keywords"
    content="BXO, LSA, balanitis xerotica obliterans, treatment, clobetasol" />
    <meta name="description"
    content="The abstract of a medical journal article" />
    <style type="text/css">
<!--
body
{
background-color: white;
color: black;
}
div.corpus
{
margin-left: 10%;
margin-right: 10%;
}
p.navlink
{
text-align: center;
}
span.yellow
{
background-color: #ff9;
}
p.library
{
font-size: 13pt;
text-align: center;
font-family: "times new roman", times, serif;
font-weight: bold;
}
span.sclibrary
{
font-size: 8.45pt;
}
-->
    </style>
  </head>

  <body bgcolor="white">
    <p class="library">T<span class="sclibrary">HE</span> C<span
    class="sclibrary">IRCUMCISION</span> R<span
    class="sclibrary">EFERENCE</span> L<span
    class="sclibrary">IBRARY</span></p>
    <hr size="1" color="black" />

    <h3>JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Volume 40,
    Number 3: Pages 451-7,<br />
     March 1999.</h3>
    <br />
    <br />

    <div class="corpus">
      <h2>Penile lichen sclerosus et atrophicus treated with<br />
       clobetasol dipropionate 0.05% cream:<br />
       a retrospective clinical and histopathological study.</h2>

      <p><b>Dahlman-Ghozlan K, Hedblad MA, von Krogh G.</b></p>

      <p>Department of Dermatovenereology,<br />
       <a
      href="http://www.karolinska.se/templates/DivisionStart____53585.aspx?epslanguage=EN"
       target="_blank">Karolinska Hospital</a>,<br />
       Stockholm, Sweden.</p>

      <p><b>BACKGROUND:</b> Treatment with clobetasol propionate
      0.05% cream is effective against lichen sclerosus et
      atrophicus (LSA) of the vulva.</p>

      <p><b>OBJECTIVE:</b> The purpose of this study was to
      retrospectively evaluate whether clinical and histologic
      responses to topical clobetasol can be accomplished in penile
      LSA.</p>

      <p><b>METHODS:</b> A self-assessment questionnaire was
      obtained from 22 men with LSA, and a clinical examination was
      performed in 21 of them. Biopsy specimens from 15 cases were
      compared before and after treatment.</p>

      <p><b>RESULTS:</b> Itching, burning, pain, dyspareunia,
      phimosis, and dysuria decreased significantly (P &lt; .001 to
      .05) after 1 to 2 daily applications, for a mean of 7.1 weeks
      (2-16 weeks). Additional operation for phimosis was required
      in 6 of the 22 men. All histologic LSA criteria were
      significantly (P &lt; .01 to .05) reduced after
      treatment.</p>

      <p><b>CONCLUSION:</b> <span class="yellow">Topical treatment
      of penile LSA with clobetasol propionate represents a safe
      and effective therapy with no risk of epidermal
      atrophy</span> but with some potential for triggering latent
      infections, most importantly human papillomavirus.</p>
    </div>
    <hr />

    Citation:
    <ul>
      <li>Dahlman-Ghozlan K, Hedblad MA, von Krogh G. Penile lichen
      sclerosus et atrophicus treated with clobetasol dipropionate
      0.05% cream: a retrospective clinical and histopathological
      study. <i>J Am Acad Dermatol</i> 1999;40(3):451-7.</li>
    </ul>

    <hr />
    <small>(File revised 7 April 2008)</small> 

    <center>
      <p class="navlink"><a href="/library/">Return to CIRP
      Library</a></p>
    </center>

    <p>
    <tt>http://www.cirp.org/library/treatment/BXO/dahlman-ghozlan1/</tt></p>
  </body>
</html>
